BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Sinagra E, Morreale GC, Mohammadian G, Fusco G, Guarnotta V, Tomasello G, Cappello F, Rossi F, Amvrosiadis G, Raimondo D. New therapeutic perspectives in irritable bowel syndrome: Targeting low-grade inflammation, immuno-neuroendocrine axis, motility, secretion and beyond. World J Gastroenterol 2017; 23(36): 6593-6627 [PMID: 29085207 DOI: 10.3748/wjg.v23.i36.6593]
URL: https://www.wjgnet.com/1007-9327/full/v23/i36/6593.htm
Number Citing Articles
1
Neha R Santucci, Miguel Saps, Miranda A van Tilburg. New advances in the treatment of paediatric functional abdominal pain disordersThe Lancet Gastroenterology & Hepatology 2020; 5(3): 316 doi: 10.1016/S2468-1253(19)30256-0
2
Kayle Dickson, Hajer Malitan, Christian Lehmann. Imaging of the Intestinal Microcirculation during Acute and Chronic InflammationBiology 2020; 9(12): 418 doi: 10.3390/biology9120418
3
Shiv Vardan Singh, Risha Ganguly, Kritika Jaiswal, Aditya Kumar Yadav, Ramesh Kumar, Abhay K Pandey. Molecular signalling during cross talk between gut brain axis regulation and progression of irritable bowel syndrome: A comprehensive reviewWorld Journal of Clinical Cases 2023; 11(19): 4458-4476 doi: 10.12998/wjcc.v11.i19.4458
4
Gisela Chelimsky, Pippa Simpson, Liyun Zhang, Doug Bierer, Steve Komas, Balaraman Kalyanaraman, Thomas Chelimsky, Takahiro Ushida. Impaired Mitochondrial Bioenergetics Function in Pediatric Chronic Overlapping Pain Conditions with Functional Gastrointestinal DisordersPain Research and Management 2021; 2021: 1 doi: 10.1155/2021/6627864
5
Robyn Rexwinkel, Arine M. Vlieger, Miguel Saps, Merit M. Tabbers, Marc A. Benninga. A therapeutic guide on pediatric irritable bowel syndrome and functional abdominal pain-not otherwise specifiedEuropean Journal of Pediatrics 2022; 181(7): 2603 doi: 10.1007/s00431-022-04459-y
6
Dae Young Lee, Hee Eun Kang. Pharmacokinetics of DA-6886, A New 5-HT4 Receptor Agonist, in RatsPharmaceutics 2022; 14(4): 702 doi: 10.3390/pharmaceutics14040702
7
Emanuele Sinagra, Francesca Rossi, Dario Raimondo, Giuseppe Conoscenti, Andrea Anderloni, Valentina Guarnotta, Marcello Maida. Tenapanor for the treatment of irritable bowel syndrome with constipationExpert Review of Clinical Pharmacology 2020; 13(5): 473 doi: 10.1080/17512433.2020.1762570
8
Yong Li, Tingting Yang, Qing Yao, Songsong Li, En Fang, Yankun Li, Chao Liu, Weimin Li. Metformin prevents colonic barrier dysfunction by inhibiting mast cell activation in maternal separation‐induced IBS‐like ratsNeurogastroenterology & Motility 2019; 31(5) doi: 10.1111/nmo.13556
9
Christopher Tait, Gregory S. Sayuk. The Brain-Gut-Microbiotal Axis: A framework for understanding functional GI illness and their therapeutic interventionsEuropean Journal of Internal Medicine 2021; 84: 1 doi: 10.1016/j.ejim.2020.12.023
10
Francesco Vito Mandarino, Emanuele Sinagra, Dario Raimondo, Silvio Danese. The Role of Microbiota in Upper and Lower Gastrointestinal Functional DisordersMicroorganisms 2023; 11(4): 980 doi: 10.3390/microorganisms11040980
11
Farouk Drissi, Jeremy Bregeon, Guillaume Gourcerol, Catherine Le Berre-Scoul, Michel Neunlist, Guillaume Meurette. Does a rectal biopsy with intestinal barrier permeability assessment could be a biomarker of sacral neuromodulation success in fecal incontinent patients?Surgery Open Digestive Advance 2024; 13: 100123 doi: 10.1016/j.soda.2023.100123
12
Ning Zhu, Liuyan Zhu, Xueliang Zhang, Chengbin Huang, Wenjun Xiang, Bingwu Huang. Triptolide attenuates irritable bowel syndrome via inhibiting ODC1BMC Gastroenterology 2023; 23(1) doi: 10.1186/s12876-023-02847-8
13
M.A. Livzan, O.V. Gaus. Fecal zonulin as a biomarker of increased intestinal permeability in patients with irritable bowel syndrome (narrative review and pilot study results)Dokazatel'naya gastroenterologiya 2021; 10(3): 47 doi: 10.17116/dokgastro20211003147
14
György Bárdos. Irritable bowel syndrome (IBS): could we decide what is behind?Biologia Futura 2024; 75(1): 61 doi: 10.1007/s42977-024-00205-7
15
Yu.M. Stepanov, I.Ya. Budzak, Yu.A. Gaidar. Morphological manifestations of irritable bowel syndromeGASTROENTEROLOGY 2021; 55(2): 108 doi: 10.22141/2308-2097.55.2.2021.233635
16
M. A. Osadchuk, A. A. Svistunov, N. V. Kireeva, M. M. Osadchuk. Functional diseases of the gastrointestinal tract in the context with overlapping functional disorders: current status of the problemTerapevticheskii arkhiv 2020; 92(2): 111 doi: 10.26442/00403660.2020.02.000458
17
Nils Günnewich, Thorsten Rose, Kathrin Koll, Kurt Appel. Magen-Darm-Entoxin® Shows Anti-Inflammatory Effects in vitroComplementary Medicine Research 2021; 28(5): 473 doi: 10.1159/000514525
18
Laura Beatrice Mattioli, Maria Frosini, Rosa Amoroso, Cristina Maccallini, Elda Chiano, Rita Aldini, Francesco Urso, Ivan Corazza, Matteo Micucci, Roberta Budriesi. Olea europea L. Leaves and Hibiscus sabdariffa L. Petals Extracts: Herbal Mix from Cardiovascular Network Target to Gut Motility Dysfunction ApplicationNutrients 2022; 14(3): 463 doi: 10.3390/nu14030463
19
Francesca Curci, Filomena Corbo, Maria Lisa Clodoveo, Lara Salvagno, Antonio Rosato, Ivan Corazza, Roberta Budriesi, Matteo Micucci, Laura Beatrice Mattioli. Polyphenols from Olive-Mill Wastewater and Biological Activity: Focus on Irritable Bowel SyndromeNutrients 2022; 14(6): 1264 doi: 10.3390/nu14061264
20
Emanuele Sinagra, Francesco Vito Mandarino, Marcello Maida, Daniela Cabibi, Francesca Rossi, Dario Raimondo, Guido Manfredi. Focal Active Colitis: What Are Its Clinical Implications? A Narrative ReviewBiomedicines 2023; 11(10): 2631 doi: 10.3390/biomedicines11102631
21
Ilmaben S Vahora, Nicholas Tsouklidis, Rajat Kumar, Ravi Soni, Safeera Khan. How Serotonin Level Fluctuation Affects the Effectiveness of Treatment in Irritable Bowel SyndromeCureus 2020;  doi: 10.7759/cureus.9871
22
Lijun Mei, Jiaoli Zhou, Yimo Su, Kunhong Mao, Jing Wu, Caicai Zhu, Ling He, Ying Cui. Gut microbiota composition and functional prediction in diarrhea-predominant irritable bowel syndromeBMC Gastroenterology 2021; 21(1) doi: 10.1186/s12876-021-01693-w
23
Xiao-Ya Li, Zhou-Jin Tan. Modern biological connotation of diarrhea with kidney-Yang deficiency syndromeWorld Chinese Journal of Digestology 2022; 30(3): 119 doi: 10.11569/wcjd.v30.i3.119
Abstract() |  Core Tip() |  Full Article(HTML)() | Times Cited  (0) | Total Visits (0) | Open
24
Yu Zhang, Lu Zhang, Shuang Li, Xia-Xin Wu, Ya-Xin Bi, Xu Hu, Yu-Qing Chen, Yuan Yuan. Serum levels of high sensitive C-reactive protein and tumor necrosis factor-alpha in different subtypes of irritable bowel syndrome and their correlationWorld Chinese Journal of Digestology 2020; 28(16): 782 doi: 10.11569/wcjd.v28.i16.782
Abstract() |  Core Tip() |  Full Article(HTML)() | Times Cited  (0) | Total Visits (0) | Open
25
L. B. Lazebnik, E. V. Golovanova, B. A. Volel, N. V. Korochanskaya, E. A. Lyalyukova, M. V. Mokshina, S. N. Mekhtiev, O. A. Mekhtieva, Z. V. Metsaeva, D. S. Petelin, V. I. Simanenkov, S. I. Sitkin, S. V. Cheremushkin, M. V. Chernogorova, А. I. Khavkin. Functional gastrointestinal disorders. Overlap syndrome Clinical guidelines of the Russian Scientific Medical Society of Internal Medicine and Gastroenterological Scientific Society of RussiaExperimental and Clinical Gastroenterology 2021; (8): 5 doi: 10.31146/1682-8658-ecg-192-8-5-117
26
Uday C Ghoshal. Marshall and Warren Lecture 2019: A paradigm shift in pathophysiological basis of irritable bowel syndrome and its implication on treatmentJournal of Gastroenterology and Hepatology 2020; 35(5): 712 doi: 10.1111/jgh.15032
27
Emanuele Sinagra, Erika Utzeri, Gaetano Cristian Morreale, Carlo Fabbri, Fabio Pace, Andrea Anderloni. Microbiota-gut-brain axis and its affect inflammatory bowel disease: Pathophysiological concepts and insights for cliniciansWorld Journal of Clinical Cases 2020; 8(6): 1013-1025 doi: 10.12998/wjcc.v8.i6.1013
28
Oscar J. Cordero, Rubén Varela-Calviño, Begoña Graña-Suárez, Alba García-López. Foundations of Colorectal Cancer2022; : 435 doi: 10.1016/B978-0-323-90055-3.00031-4
29
Francesco Vito Mandarino, Emanuele Sinagra, Alberto Barchi, Maria Chiara Verga, Daniele Brinch, Dario Raimondo, Silvio Danese. Gastroparesis: The Complex Interplay with Microbiota and the Role of Exogenous Infections in the Pathogenesis of the DiseaseMicroorganisms 2023; 11(5): 1122 doi: 10.3390/microorganisms11051122
30
Yoshiharu Uno. Hypothesis: Mechanism of irritable bowel syndrome in inflammatory bowel diseaseMedical Hypotheses 2019; 132: 109324 doi: 10.1016/j.mehy.2019.109324
31
Ming Xia. Visceral Pain2024; : 199 doi: 10.1007/978-981-99-9167-9_11
32
Oscar J. Cordero, Rubén Varela-Calviño, Begoña Graña-Suárez. Cancer Immunology2020; : 261 doi: 10.1007/978-3-030-57949-4_10
33
Biljana Radovanovic-Dinic, Snezana Tesic-Rajkovic, Sasa Grgov, Gordana Petrovic, Valentina Zivkovic. Irritable bowel syndrome - from etiopathogenesis to therapyBiomedical Papers 2018; 162(1): 1 doi: 10.5507/bp.2017.057
34
Yu Zhang, Xia‐Xin Wu, Shuang Li, Jin‐Feng Wu, Sen Han, Zhi‐Jie Lin, Shi‐Zhen Ding, Wei‐Juan Gong. Peroxiredoxin 1 as an inflammatory marker in diarrhea‐predominant and postinfectious irritable bowel syndromeNeurogastroenterology & Motility 2020; 32(2) doi: 10.1111/nmo.13741
35
Vassilia Theodorou, Catherine Beaufrand, Sophie Yvon, Guylaine Laforge, Yvonne Burmeister, Andrea Müller, Bernd Seilheimer, Lionel Bueno, Helene Eutamene. The multicomponent medication Spascupreel attenuates stress‐induced gut dysfunction in ratsNeurogastroenterology & Motility 2020; 32(5) doi: 10.1111/nmo.13798
36
Tingting Cai, Xiang Wang, Bangjie Li, Fei Xiong, Hao Wu, Xinghao Yang. Deciphering the synergistic network regulation of active components from SiNiSan against irritable bowel syndrome via a comprehensive strategy: Combined effects of synephrine, paeoniflorin and naringinPhytomedicine 2021; 86: 153527 doi: 10.1016/j.phymed.2021.153527